Since the emergence of COVID-19 in Dec. 2019, our knowledge of disease and treatment
modalities has evolved significantly. Pregnancy poses a unique challenge in the
context of the management of infectious diseases because of the effect of the
disease and treatment modalities on the mother and fetus. There has been a lack
of active inclusion of pregnant women in various trials including vaccination
trials in COVID-19; hence most information on treatment strategies became
available from adult non-pregnant population. This article outlines the short
review on current management strategies available to the adult pregnant
population with COVID-19 in light of available evidence until 30th April 2021.
References
[1]
WHO Coronavirus (COVID-19) Dashboard.
[2]
Umer, S., et al. (2021) International Outcomes of COVID-19 during Pregnancy and a Literature Review on Maternal and Neonatal Outcomes. Open Journal of Obstetrics and Gynecology, 11, 450-460. https://doi.org/10.4236/ojog.2021.114043
[3]
Knight, M., Bunch, K., Vousden, N., Morris, E., et al. (2020) Characteristics and Outcomes of Pregnant Women Admitted to Hospital with Confirmed SARS-CoV-2 Infection in UK: National Population-Based Cohort Study. BMJ, 369, m2107.
https://doi.org/10.1101/2020.05.08.20089268
[4]
Horby, P., et al. (2020) Dexamethasone in Hospitalized Patients with Covid-19: Preliminary Report. New England Journal of Medicine.
[5]
COVID-19 Rapid Guideline: Antibiotics for Pneumonia in Adults in Hospital; NICE May 2020.
[6]
Hadisi, Z., Walsh, T., Dabiri, S.M.H., Seyfoori, A., et al. (2020) Management of Coronavirus Disease 2019 (COVID-19) Pandemic: From Diagnosis to Treatment Strategies. Advanced Therapeutics, 4, Article ID: 2000173.
https://doi.org/10.1002/adtp.202000173
[7]
Risk Stratification of Patients Admitted to Hospitals with COVID-19 Using the ISARIC WHO Clinical Characteristics Protocol: Development and Validation of the 4C Mortality Score.
[8]
D’Souza, R., Malhamé, I., Teshler, L., Acharya, G., Hunt, B.J. and McLintock, C. (2020) A Critical Review of the Pathophysiology of Thrombotic Complications and Clinical Practice Recommendations for Thromboprophylaxis in Pregnant Patients with COVID-19. Acta Obstetricia et Gynecologica Scandinavica, 99, 1110-1120.
https://doi.org/10.1111/aogs.13962
[9]
Coronavirus Infection in Pregnancy. Information for Healthcare Professionals, Version II: 2020, July.
https://www.rcog.org.uk/globalassets/documents/guidelines/2020-07-24-coronavirus-covid-19-infection-in-pregnancy.pdf
[10]
Gordon, A.C., et al. (2021) REMAP-CAP Investigators; Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19-Preliminary Report.
[11]
Sadeghipour, P., et al. (2021) Effect of Intermediate-Dose vs. Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality among Patients with COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial. JAMA, 325, 1620-1630.
[12]
Saad, A.F., Chappell, L., Saade, G.R. and Pacheco, L.D. (2020) Corticosteroids in the Management of Pregnant Patients with Coronavirus Disease (COVID-19). Obstetrics & Gynecology, 136, 823-826. https://doi.org/10.1097/AOG.0000000000004103
[13]
WHO (2020) Solidatory Trial Consortium. Repurposed Antiviral Drugs for COVID-19-Interim WHO Solidatory Trial Results.
[14]
Beigel, J., et al. (2020) Remdesivir for the Treatment of COVID-19 Final Report. The New England Journal of Medicine, 383, 1813-1826.
[15]
Khan, F.A., Stewart, I., Fabbri, L., Moss, S., et al. (2021) Systematic Review and Meta-Analysis of Anakinra, Sarilumab, Siltuximab and Tocilizumab for COVID-19. Thorax, 1-13. https://doi.org/10.1136/thoraxjnl-2020-215266
[16]
Horby, P.W., et al. (2021) Tocilizumab in Patients Admitted to Hospital with COVID-19 (RECOVERY): Preliminary Results of a Randomised, Controlled, Open-Label, Platform Trial.
[17]
Libster, R., Marc, G.P., Wappner, D., Coviello, S., et al. (2021) Early High-Titre Plasma Therapy to Prevent Severe Ccovid-19 in Older Adults. The New England Journal of Medicine, 384, 610-618. https://doi.org/10.1056/NEJMoa2033700
[18]
Helping Alleviate the Longer-Term Consequences of COVID-19 (HEAL-COVID) (HEAL-COVID). https://clinicaltrials.gov/ct2/show/NCT04801940
[19]
COVID-19 Vaccines, Pregnancy and Breastfeeding; RCOG.
https://www.rcog.org.uk/en/guidelines-research-services/coronavirus-covid-19-pregnancy-and-womens-health/covid-19-vaccines-and-pregnancy/covid-19-vaccines-pregnancy-and-breastfeeding
Public Health England Guide.
https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/980176/PHE_11920_COVID-19_vaccination_pregnancy_v4.pdf
[22]
(2021) COVID-19 Vaccines and Fertility. British Fertility Society.
[23]
Gray, K.J., et al. (2021) COVID-19 Vaccine Response in Pregnant and Lactating Women: A Cohort Study. American Journal of Obstetrics and Gynecology.
[24]
(2021) RCOG Statement in Response to Change in Guidance around the Oxford Astra Zeneca Vaccine.
[25]
Joint Committee on Vaccination and Immunisation: Advice on Priority Groups for COVID-19 Vaccination.
https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/948338/jcvi-advice-on-priority-groups-for-covid-19-vaccination-30-dec-2020.pdf
[26]
Coronavirus Infection and Pregnancy; Information for Pregnant Women and Their Families; RCOG.
https://www.rcog.org.uk/en/guidelines-research-services/guidelines/coronavirus-pregnancy/covid-19-virus-infection-and-pregnancy
[27]
John Hopkins Coronavirus Resource Centre. https://coronavirus.jhu.edu/map.html
